Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 24/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Svetlana up on 2025-1-4

Curated date: 2024/11/11

Curator: KateRasheed

Revision editor(s): KateRasheed, WikiWorks

Source: Additional file 12: Figure S12

Description: Differentially abundant taxa between the VANM group and Isoniazid treatment group.

Abundance in Group 1: increased abundance in H (Isoniazid)

NCBI	Quality Control	Links
Acetanaerobacterium
Acetatifactor
Akkermansia
Alistipes
Anaerosporobacter
Anaerotruncus
Anaerovorax
Arthrobacter
Asaccharobacter
Bacteroides
Barnesiella
Blautia
Butyricicoccus
Christensenella
Coprobacter
Dorea
Dysgonomonas
Eisenbergiella
Enterorhabdus
Erysipelothrix
Erysipelotrichaceae
Ethanoligenens
Flavonifractor
Gordonibacter
Guggenheimella
Hydrogenoanaerobacterium
Intestinimonas
Lachnospiraceae
Marvinbryantia
Mucispirillum
Oscillibacter
Pediococcus
Pseudobacteroides
Pseudoflavonifractor
Robinsoniella
Romboutsia
Roseburia
Ruminococcus
Sporobacter
Stomatobaculum
Tannerella
Thomasclavelia
Tyzzerella
Eubacterium

Revision editor(s): KateRasheed, WikiWorks